Cytosorbents
CTSO
#9906
Rank
โ‚น3.63 B
Marketcap
โ‚น57.82
Share price
-4.43%
Change (1 day)
-33.20%
Change (1 year)

Market capitalization of Cytosorbents (CTSO)

Market cap: โ‚น3.63 Billion

As of February 2026 Cytosorbents has a market cap of โ‚น3.63 Billion. This makes Cytosorbents the world's 9906th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytosorbents from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น3.63 B-5.29%
2025โ‚น3.83 B-13.47%
2024โ‚น4.43 B-8.09%
2023โ‚น4.82 B-13.86%
2022โ‚น5.59 B-58.72%
2021โ‚น13.55 B-46.18%
2020โ‚น25.19 B181.34%
2019โ‚น8.95 B-50.12%
2018โ‚น17.95 B50.76%
2017โ‚น11.90 B26.24%
2016โ‚น9.43 B0.34%
2015โ‚น9.40 B-36.03%
2014โ‚น14.69 B657.22%
2013โ‚น1.94 B26.84%
2012โ‚น1.53 B1.91%
2011โ‚น1.50 B94.84%
2010โ‚น0.77 B31.69%
2009โ‚น0.58 B502.37%
2008โ‚น97.14 M

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Cytosorbents was reported to be:

โ‚น3.63 Billion
by Nasdaq info icon info icon
โ‚น3.63 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Boston Scientific
BSX
โ‚น12.729 T 350,464.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚น1.535 T 42,177.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚น136.63 B 3,662.84%๐Ÿ‡บ๐Ÿ‡ธ USA